Aspirin Metabolites and Mammographic Breast Density in Premenopausal Women.

Ramkrishna Kumar Singh Kayla R Getz Joy K Kyeyune Myung Sik Jeon Chongliang Luo Jingqin R Luo Adetunji T Toriola

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)

Given the null results, additional research investigating the associations of aspirin metabolites in breast tissue and MBD is necessary. Impact: Elucidating the determinants of MBD, a strong risk factor for breast cancer, can play an important role in breast cancer prevention. Future studies should determine the associations of nonaspirin NSAID metabolites with MBD.

Keyphrases

breast cancer risk
ms ms
low dose
cardiovascular events
antiplatelet therapy
polycystic ovary syndrome
postmenopausal women
type diabetes
cardiovascular disease
metabolic syndrome
current status
insulin resistance
anti inflammatory drugs
acute coronary syndrome
young adults